Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 31, 2022

Conditions
Type 1 Diabetes
Interventions
BIOLOGICAL

Covid-19 vaccination

"Correct Covid19 vaccination status was considered in the following situation:~Received at least two Covid-19 vaccine doses being the last in the last 6 months."

BIOLOGICAL

Influenza vaccination

"Correct influenza vaccination status was considered in the following situation:~\- Received at least one Influenza vaccine dose in the last year."

BIOLOGICAL

Pneumococal vaccination

"Correct pneumococal vaccination status was considered if a subject received at least one of the following options:~One pneumococcal conjugate vaccine (PCV) 13 dose in the last year. One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.~One PPSV 23 dose in the last 5 years. One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year."

BIOLOGICAL

Hepatitis B Virus (HBV) vaccination

"Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation:~.- Received at least three consecutive doses of HBV vaccine during six consecutive months."

Trial Locations (1)

13005

Ciudad Real General University Hospital, Ciudad Real

All Listed Sponsors
lead

Castilla-La Mancha Health Service

OTHER